One thing worth reading this week
15 November 2026 · Curated for research-led data visualisation & design practice
What the Label Won’t Tell You
By Dhruvi Mehta
By building a custom scoring system to analyze ingredient lists, this project investigates whether luxury skincare products offer poorer formulation value than their affordable alternatives.
This gives you a clear model for translating messy, text-based disclosures into quantitative data structures. Pay attention to how the author establishes a classification hierarchy (from superstars to baseline ingredients) to make qualitative marketing claims measurable. This is useful if you're looking for ways to audit hidden discrepancies between surface narratives and underlying metrics in your own research-led visualization work.
▸Full Academic Abstract & CitationExpand
Full Abstract
“The $390 moisturiser and the $15 one are sitting side by side at Sephora. The $390 one has a better bottle. More or less, that is what the data says. Every skincare product sold in the United States is required by law to print its full ingredient list on the packaging, ordered by descending concentration. The ingredient at the top is present in the highest amount. The one at the bottom is present in the least amount. It is one of the few genuinely transparent disclosures the beauty industry makes, and almost nobody reads it. I started reading ingredient lists obsessively after my mum kept asking me to buy her La Mer’s The New Moisturizing Soft Cream for $390 from Sephora. The entire product is built around a single proprietary ingredient: Miracle Broth, an algae extract that is listed first. Positions two through six are silicones and petrolatum. The peptides and hyaluronic acid it is also marketed around appear past position 38. You are paying $390 for one hero ingredient surrounded by filler. To be clear: Low concentration does not always mean ineffective. Some active ingredients are clinically meaningful at 0.1%, and a well-formulated product might place its hero ingredient lower in the list by design. The issue here is not where the actives appear. It is that the product is sold as though they are the story—named for them, priced for them—when the formula is mostly silicone. The gap is between what the label claims and what the ingredient list confirms. That gap has a name now. Dupe culture has turned ingredient-list literacy into a mainstream pastime, with millions of people asking whether the $90 version is actually better than the $12 one. The answer they usually get is a side-by-side texture comparison, someone’s skin looking good on camera. What they rarely get is the formula. This frustration led me to several questions: Is this pattern consistent? Are luxury skincare products systematically poorer value at the formulation level than their affordable counterparts? And if so, by how much? To find out, I built a scoring system from scratch and ran it on 16 products, eight head-to-head pairs, each pairing a luxury or premium brand with its closest affordable equivalent in the same category. The result is “ Beyond the Label .” The methodology, briefly Ingredient lists from INCIDecoder, a publicly accessible cosmetic ingredient database, are classified into four categories: superstars (rare, high-impact actives), goodies (beneficial but baseline contr”
“A visualisation does not merely communicate data; it shapes what people consider relevant, uncertain, and actionable.”